Bicycle Therapeutics Statistics
Total Valuation
BCYC has a market cap or net worth of $438.41 million. The enterprise value is -$204.18 million.
Important Dates
The last earnings date was Thursday, October 30, 2025, before market open.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BCYC has 69.37 million shares outstanding. The number of shares has increased by 34.28% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 69.37M |
| Shares Change (YoY) | +34.28% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 1.45% |
| Owned by Institutions (%) | 38.38% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.44 |
| Forward PS | 14.18 |
| PB Ratio | 0.71 |
| P/TBV Ratio | 0.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.66, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.66 |
| Quick Ratio | 10.33 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,442.89 |
Financial Efficiency
Return on equity (ROE) is -34.59% and return on invested capital (ROIC) is -24.72%.
| Return on Equity (ROE) | -34.59% |
| Return on Assets (ROA) | -20.59% |
| Return on Invested Capital (ROIC) | -24.72% |
| Return on Capital Employed (ROCE) | -41.75% |
| Revenue Per Employee | $92,915 |
| Profits Per Employee | -$821,836 |
| Employee Count | 305 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.96% in the last 52 weeks. The beta is 1.47, so BCYC's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | -68.96% |
| 50-Day Moving Average | 7.49 |
| 200-Day Moving Average | 8.22 |
| Relative Strength Index (RSI) | 38.12 |
| Average Volume (20 Days) | 375,770 |
Short Selling Information
| Short Interest | 1.50M |
| Short Previous Month | 1.54M |
| Short % of Shares Out | 3.89% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.98 |
Income Statement
In the last 12 months, BCYC had revenue of $28.34 million and -$250.66 million in losses. Loss per share was -$3.62.
| Revenue | 28.34M |
| Gross Profit | -210.90M |
| Operating Income | -290.02M |
| Pretax Income | -252.86M |
| Net Income | -250.66M |
| EBITDA | -283.23M |
| EBIT | -290.02M |
| Loss Per Share | -$3.62 |
Full Income StatementBalance Sheet
The company has $648.33 million in cash and $5.74 million in debt, giving a net cash position of $642.58 million or $9.26 per share.
| Cash & Cash Equivalents | 648.33M |
| Total Debt | 5.74M |
| Net Cash | 642.58M |
| Net Cash Per Share | $9.26 |
| Equity (Book Value) | 618.48M |
| Book Value Per Share | 8.92 |
| Working Capital | 669.54M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$239.73 million and capital expenditures -$2.14 million, giving a free cash flow of -$241.87 million.
| Operating Cash Flow | -239.73M |
| Capital Expenditures | -2.14M |
| Free Cash Flow | -241.87M |
| FCF Per Share | -$3.49 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,023.40% |
| Pretax Margin | -892.25% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BCYC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.28% |
| Shareholder Yield | -34.28% |
| Earnings Yield | -57.18% |
| FCF Yield | -55.17% |
Analyst Forecast
The average price target for BCYC is $20.73, which is 228.01% higher than the current price. The consensus rating is "Buy".
| Price Target | $20.73 |
| Price Target Difference | 228.01% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 58.92% |
| EPS Growth Forecast (5Y) | 0.42% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BCYC has an Altman Z-Score of 1.71 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.71 |
| Piotroski F-Score | 1 |
